The story of Viagra, formerly marketed by copyright, presents a intricate case study for investors considering the healthcare landscape . Although its groundbreaking success and creation of countless in earnings , the intellectual property expiration has opened the floodgates for generic medications, substantially eroding profit potential . This sh